These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 27222100)
41. Zinc inhibits p75NTR-mediated apoptosis in chick neural retina. Allington C; Shamovsky IL; Ross GM; Riopelle RJ Cell Death Differ; 2001 May; 8(5):451-6. PubMed ID: 11423905 [TBL] [Abstract][Full Text] [Related]
42. Nerve growth factor stimulation of ERK1/2 phosphorylation requires both p75NTR and α9β1 integrin and confers myoprotection towards ischemia in C2C12 skeletal muscle cell model. Ettinger K; Lecht S; Arien-Zakay H; Cohen G; Aga-Mizrachi S; Yanay N; Saragovi HU; Nedev H; Marcinkiewicz C; Nevo Y; Lazarovici P Cell Signal; 2012 Dec; 24(12):2378-88. PubMed ID: 22960610 [TBL] [Abstract][Full Text] [Related]
43. Nerve growth factor receptor role on rabbit sperm storage. Castellini C; Mattioli S; Bosco AD; Cotozzolo E; Cartoni Mancinelli A; Rende M; Stabile AM; Pistilli A Theriogenology; 2020 Sep; 153():54-61. PubMed ID: 32442740 [TBL] [Abstract][Full Text] [Related]
44. Reciprocal modulation of TrkA and p75NTR affinity states is mediated by direct receptor interactions. Ross GM; Shamovsky IL; Lawrance G; Solc M; Dostaler SM; Weaver DF; Riopelle RJ Eur J Neurosci; 1998 Mar; 10(3):890-8. PubMed ID: 9753156 [TBL] [Abstract][Full Text] [Related]
45. Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR. Pedraza CE; Podlesniy P; Vidal N; Arévalo JC; Lee R; Hempstead B; Ferrer I; Iglesias M; Espinet C Am J Pathol; 2005 Feb; 166(2):533-43. PubMed ID: 15681836 [TBL] [Abstract][Full Text] [Related]
46. Existence of nerve growth factor receptors, tyrosine kinase a and p75 neurotrophin receptors in intervertebral discs and on dorsal root ganglion neurons innervating intervertebral discs in rats. Sugiura A; Ohtori S; Yamashita M; Inoue G; Yamauchi K; Koshi T; Suzuki M; Norimoto M; Orita S; Eguchi Y; Takahashi Y; Watanabe TS; Ochiai N; Takaso M; Takahashi K Spine (Phila Pa 1976); 2008 Sep; 33(19):2047-51. PubMed ID: 18758359 [TBL] [Abstract][Full Text] [Related]
47. Nerve growth factor & TrkA as novel therapeutic targets in cancer. Demir IE; Tieftrunk E; Schorn S; Friess H; Ceyhan GO Biochim Biophys Acta; 2016 Aug; 1866(1):37-50. PubMed ID: 27264679 [TBL] [Abstract][Full Text] [Related]
48. Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells. Li H; Qi Y; Li C; Braseth LN; Gao Y; Shabashvili AE; Katovich MJ; Sumners C Mol Cancer Ther; 2009 Dec; 8(12):3255-65. PubMed ID: 19996275 [TBL] [Abstract][Full Text] [Related]
49. Caspase-2 and p75 neurotrophin receptor (p75NTR) are involved in the regulation of SREBP and lipid genes in hepatocyte cells. Pham DD; Bruelle C; Thi Do H; Pajanoja C; Jin C; Srinivasan V; Olkkonen VM; Eriksson O; Jauhiainen M; Lalowski M; Lindholm D Cell Death Dis; 2019 Jul; 10(7):537. PubMed ID: 31296846 [TBL] [Abstract][Full Text] [Related]
50. 5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors. Gravina GL; Marampon F; Di Staso M; Bonfili P; Vitturini A; Jannini EA; Pestell RG; Tombolini V; Festuccia C Prostate; 2010 Aug; 70(11):1166-78. PubMed ID: 20333699 [TBL] [Abstract][Full Text] [Related]
51. Inhibition of human prostate cancer cells proliferation by a selective alpha1-adrenoceptor antagonist labedipinedilol-A involves cell cycle arrest and apoptosis. Liou SF; Lin HH; Liang JC; Chen IJ; Yeh JL Toxicology; 2009 Feb; 256(1-2):13-24. PubMed ID: 19056458 [TBL] [Abstract][Full Text] [Related]
52. Sortilin is essential for proNGF-induced neuronal cell death. Nykjaer A; Lee R; Teng KK; Jansen P; Madsen P; Nielsen MS; Jacobsen C; Kliemannel M; Schwarz E; Willnow TE; Hempstead BL; Petersen CM Nature; 2004 Feb; 427(6977):843-8. PubMed ID: 14985763 [TBL] [Abstract][Full Text] [Related]
53. Functionally antagonistic interactions between the TrkA and p75 neurotrophin receptors regulate sympathetic neuron growth and target innervation. Kohn J; Aloyz RS; Toma JG; Haak-Frendscho M; Miller FD J Neurosci; 1999 Jul; 19(13):5393-408. PubMed ID: 10377349 [TBL] [Abstract][Full Text] [Related]
54. NADE, a p75NTR-associated cell death executor, is involved in signal transduction mediated by the common neurotrophin receptor p75NTR. Mukai J; Hachiya T; Shoji-Hoshino S; Kimura MT; Nadano D; Suvanto P; Hanaoka T; Li Y; Irie S; Greene LA; Sato TA J Biol Chem; 2000 Jun; 275(23):17566-70. PubMed ID: 10764727 [TBL] [Abstract][Full Text] [Related]
55. Neurotrophins induce sphingomyelin hydrolysis. Modulation by co-expression of p75NTR with Trk receptors. Dobrowsky RT; Jenkins GM; Hannun YA J Biol Chem; 1995 Sep; 270(38):22135-42. PubMed ID: 7673191 [TBL] [Abstract][Full Text] [Related]
56. TrkA mediates developmental sympathetic neuron survival in vivo by silencing an ongoing p75NTR-mediated death signal. Majdan M; Walsh GS; Aloyz R; Miller FD J Cell Biol; 2001 Dec; 155(7):1275-85. PubMed ID: 11756477 [TBL] [Abstract][Full Text] [Related]
57. TrkA-expressing trigeminal sensory neurons display both neurochemical and structural plasticity despite a loss of p75NTR function: responses to normal and elevated levels of nerve growth factor. Krol KM; Stein EJ; Elliott J; Kawaja MD Eur J Neurosci; 2001 Jan; 13(1):35-47. PubMed ID: 11135002 [TBL] [Abstract][Full Text] [Related]
58. Distinction between differentiation, cell cycle, and apoptosis signals in PC12 cells by the nerve growth factor mutant delta9/13, which is selective for the p75 neurotrophin receptor. Hughes AL; Messineo-Jones D; Lad SP; Neet KE J Neurosci Res; 2001 Jan; 63(1):10-9. PubMed ID: 11169609 [TBL] [Abstract][Full Text] [Related]
59. Changes in Plasma β-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression. Crispoltoni L; Stabile AM; Pistilli A; Venturelli M; Cerulli G; Fonte C; Smania N; Schena F; Rende M J Alzheimers Dis; 2017; 55(3):1005-1017. PubMed ID: 27802234 [TBL] [Abstract][Full Text] [Related]
60. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells. Gravina GL; Festuccia C; Millimaggi D; Dolo V; Tombolini V; de Vito M; Vicentini C; Bologna M Prostate; 2008 May; 68(7):793-801. PubMed ID: 18324645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]